Vimarsana
Biggest News Aggregation in the World

Page 4 - Mark Kaplan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Kaplan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Kaplan Today - Breaking & Trending Today

UNLV shooting aftermath will be traumatic, experts say | Education - Vimarsana News

UNLV shooting aftermath will be traumatic, experts say | Education

A gunman killed three people and seriously injured a fourth on Wednesday at UNLV’s campus. The shooting began inside Beam Hall, which houses the Lee Business School.

UCLA in the News November 8, 2023 - Vimarsana News

UCLA in the News November 8, 2023

Highlights from Marketplace Morning Report, Insider, CNBC and others.

Source: ucla.edu
Don't focus on mass shooters' parents, a gun violence expert says. Here's what we can do to stop the carnage. - Vimarsana News

Don't focus on mass shooters' parents, a gun violence expert says. Here's what we can do to stop the carnage.

Robert Crimo Jr, the father of the Highland Park shooting suspect, pleaded guilty this week. A gun violence expert said punishing parents won't make a difference.

Source: yahoo.com
Gun Violence Expert Speaks on Highland Park Shooting Suspect's Father's Plea - Vimarsana News

Gun Violence Expert Speaks on Highland Park Shooting Suspect's Father's Plea

Robert Crimo Jr, the father of the Highland Park shooting suspect, pleaded guilty this week. A gun violence expert said punishing parents won't make a difference.

Bristol Myers Squibb's First Disclosures and New Data at ASH 2023 Highlight Company's Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology -November 02, 2023 at 11:35 am EDT - Vimarsana News

Bristol Myers Squibb's First Disclosures and New Data at ASH 2023 Highlight Company's Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology -November 02, 2023 at 11:35 am EDT

First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...